Loading...
Predictors of Sustained Response to Rivastigmine in Patients With Alzheimer's Disease: A Retrospective Analysis
Objective: The cholinesterase inhibitor rivastigmine is approved for the treatment of mild to moderate Alzheimer's disease. However, it is not possible to predict which individuals will benefit from treatment. This retrospective analysis of an international, 24-week, randomized, double-blind tr...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Physicians Postgraduate Press, Inc.
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3184571/ https://ncbi.nlm.nih.gov/pubmed/21977379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/PCC.10m01101 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|